Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)

Anotace

for CAR T-Cell Therapy, coordinate with RECEPTORS, CHIMERIC ANTIGEN

DUI

D016219 MeSH Prohlížeč

CUI

M0024767

Předchozí užití

Immunization, Passive (1983-1990)

Historická pozn.

1991